Centres and networks
Our Imperial Centres and Networks of Excellence
The Imperial Centres of Excellence aim to galvanise a critical mass of researchers, transcending Faculty boundaries to support a multidisciplinary theme. The Imperial Networks of Excellence aim to establish and grow connections around an important multidisciplinary area that is being explored at an earlier stage than the centres. See a full list of Imperial's Centres and Networks.
Imperial Centres and Networks of Excellence
The Microbiome@Imperial Network brings together researchers from across Imperial to foster an integrated forum for coordination of internal resources and strategic research efforts, to facilitate access to enabling technologies and to educate the next generation of microbiome scientists and the public.
Our other centres and initiatives
Centres and Networks
Asmarley Centre for Genomic Medicine
The Centre's scientists are recognised internationally for their extensive expertise in human molecular genetics and genomics, including large-scale studies of asthma, atopic dermatitis, psoriasis, lung and pleural cancer, and sequence-based studies of the lung microbiome.
Margaret Turner Warwick Centre for Fibrosing Lung Disease
The goal of the MTW Centre, the UK's only centre for fibrosing lung diseases, is to increase fundamental knowledge of fibrosis biology to develop, evaluate and implement novel, safe, and effective treatments that will ultimately lead to a cure for pulmonary fibrosis.
NIHR HPRU in Respiratory Infections
The National Institute for Health Research Health Protection Research Unit in Respiratory Infections is funded through the Department of Health to improve the health and wealth of the nation through research. The NIHR HPRU in respiratory Infections supports research projects across influenza, tuberculosis and other respiratory infections.
Strategic Research Centre for Pseudomonas in Cystic Fibrosis
Strategic Research Centres bring together scientists from across the UK and beyond to work on research to benefit people with cystic fibrosis. At NHLI the work is led by Prof Jane Davies seeking to address the major challenges posed by Pseudomonas aeruginosa.